Government updates

Covid Guidance Toolkit

Updated guidance around Covid came into place on February 24th and whilst there is no longer a legal requirement for people with Covid-19 to isolate, the updated published guidance outlines measures that align with the previous legal requirement to manage risk. COVID-19: people with COVID-19 and their contacts.

Specific schools guidance is outlined in the updated Contingency Framework and Operational Guidance.


COVID-19 vaccination: resources for children aged 5 to 11 years

Information for parents of eligible at risk children aged 5 to 11 years on COVID-19 vaccination.

Change made: added links to translated versions of the what to expect leaflet.


Regulatory approval of Pfizer/BioNTech vaccine for COVID-19

Information for healthcare professionals and the public about the Pfizer/BioNTech vaccine.

Change made: PIL and SMPC Comirnaty 10 mg/dose concentrate: updated title to include reference to orange cap. Updated the shelf life from 6 months to 9 months. SMPC and PIL Comirnaty 30mg/dose concentrate: Updated title to include reference to purple cap. Includes new reference to the fact there is now paediatric formulation available for children 5 to 11 years of age. Myo/pericarditis changed from a potential side effect of unknown frequency to “very rare”. Erythema multiforme added as a potential side effect with unknown frequency. Wording around shelf life updated.